Navigation Links
DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
Date:4/5/2013

San Diego, CA (PRWEB) April 05, 2013

The medication resource center DrugRisks.com is announcing new information on the site for patients taking the blood thinner Pradaxa. Researchers warned this month that use of the drug may make patients more prone to viral infections****.

DrugRisks was created to reduce the danger of side effects from popular prescription drugs by providing patients with the latest warnings, recalls, studies and legal news. Visitors can discuss side effect concerns with their doctor and decide if they need legal advice.

Health experts have disagreed about whether Pradaxa is associated with higher risks for internal bleeding. The FDA has updated its information to state the drug is as safe as warfarin*. However, the Institute for Safe Medication Practices recently ranked these blood thinners among the most dangerous drugs available and warned that patients with bleeding from Pradaxa were nearly 5 times as likely to die than those with warfarin bleeding**.

DrugRisks has also added a study from the University of Illinois at Chicago which showed the data used by the FDA may be flawed, and the risk for Pradaxa bleeding may be higher than previously thought***.

In the latest news added to DrugRisks, researchers at the University of North Carolina have discovered that the blood-thinning properties of Pradaxa may also make patients more susceptible to certain viral infections such as flu and myocarditis****.

The resource center has learned that due to the number of patients who have filed a Pradaxa lawsuit over allegations of internal bleeding, cases have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Anyone affected by internal bleeding after taking Pradaxa is encouraged to speak with a lawyer about their legal options. Since federal drug injury cases can be very specialized, DrugRisks only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugRisks.com today for more information on the research, Pradaxa side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*fda.gov/Drugs/DrugSafety/ucm326580.htm
**Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
***http://www.dailyrx.com/dabigatran-prevent-stroke-and-blood-clots-may-cause-excess-bleeding-reports-are-conflicting
****http://www.sciencedaily.com/releases/2013/04/130401132058.htm

Read the full story at http://www.prweb.com/releases/2013-pradaxa-lawsuit/update-news/prweb10602607.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
2. DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
3. DrugRisks Center NuvaRing Lawsuit News: Drug Maker May Have Concealed Risks
4. DrugRisks Stryker Recall Update: Company Warns Investors as Patients Alleging Injury Ask to Send Lawsuits to Federal Court
5. Study Suggests Vaccine May Help Kids With Brain Cancer
6. Study reveals how cancer drug causes diabetic-like state
7. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
8. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
9. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
10. No Added Cancer Risk From Hip Replacement Materials: Study
11. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... 2017 , ... An August 3rd article on Reuters covers a new University of ... JAMA (the Journal of the American Medical Association). The study found that a lower percentage ... 30, when compared to patients with lower BMIs. At present, weight loss patients must have ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Data Council, the leading ... was acquired by Advantage Solutions. The Data Council’s IX-ONE platform is the ... industry’s leading suppliers, brokers, distributors and retailers. The Data Council will become a ...
(Date:8/16/2017)... ... August 16, 2017 , ... In ... They celebrate 30 years in business this year, and they’re marking the milestone ... space to serve their patients. , It stands to reason that, given ...
(Date:8/16/2017)... ... August 16, 2017 , ... Modern Consulting Insurance & ... program. Partnering once again with Boys & Girls Clubs of Greater Kansas City, ... area’s very own American Idol. With all proceeds benefitting local worthy causes, donations ...
(Date:8/16/2017)... ... ... Paul Vitenas, MD, FACS , is honored to announce that he ... the nation’s top physicians, in a variety of specialties. This marks the fourth year ... Connolly’s coveted ranking. , Castle Connolly is the nation’s trusted provider of information on ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... , Aug. 2, 2017 ... Who,s Who as a Pinnacle Lifetime Professional in ... Key Account Manager at Turing Pharmaceuticals, AG. Her ... troubleshooting and relationship building.                ... more than 25 years of experience as a ...
(Date:8/1/2017)... 2017   CerSci Therapeutics , a non-opioid drug ... , has received notice from the National Institute on ... (NIH) that it has been awarded a Direct-to-Phase II ... in 2017 with an additional $1,000,000 to follow in ... application of their lead non-opioid drug candidate CT-044 to ...
(Date:7/28/2017)... July 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") ... third quarter ended June 30, 2017, and updated its ... For the fiscal third quarter, Hill-Rom ... $0.68 per diluted share in the prior-year period. These ... $0.39 per diluted share primarily related to the non-cash ...
Breaking Medicine Technology: